This company is no longer active
DNAC Stock Overview
Social Capital Suvretta Holdings Corp. III does not have significant operations. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Social Capital Suvretta Holdings Corp. III Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$8.63 |
52 Week High | US$10.55 |
52 Week Low | US$8.03 |
Beta | 0 |
11 Month Change | -12.65% |
3 Month Change | -12.87% |
1 Year Change | -13.53% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -14.64% |
Recent News & Updates
Recent updates
Shareholder Returns
DNAC | US Capital Markets | US Market | |
---|---|---|---|
7D | 2.6% | 2.5% | 1.6% |
1Y | -13.5% | 55.7% | 32.3% |
Return vs Industry: DNAC exceeded the US Capital Markets industry which returned -21.1% over the past year.
Return vs Market: DNAC exceeded the US Market which returned -18.7% over the past year.
Price Volatility
DNAC volatility | |
---|---|
DNAC Average Weekly Movement | 6.4% |
Capital Markets Industry Average Movement | 3.8% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.2% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: DNAC has not had significant price volatility in the past 3 months.
Volatility Over Time: DNAC's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2021 | n/a | Chamath Palihapitiya | n/a |
Social Capital Suvretta Holdings Corp. III does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on searching for a target business operating in the biotechnology industry and within the organ space sub-sector.
Social Capital Suvretta Holdings Corp. III Fundamentals Summary
DNAC fundamental statistics | |
---|---|
Market cap | US$275.21m |
Earnings (TTM) | -US$6.77m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-40.7x
P/E RatioIs DNAC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
DNAC income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$6.77m |
Earnings | -US$6.77m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.21 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | -0.4% |
How did DNAC perform over the long term?
See historical performance and comparison